RxSight, Inc.
RXST · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,336,272 | $1,389,230 | $350,477 | $307,876 |
| - Cash | $16,706 | $9,692 | $11,834 | $24,361 |
| + Debt | $12,296 | $3,012 | $44,995 | $44,931 |
| Enterprise Value | $1,331,862 | $1,382,550 | $383,638 | $328,446 |
| Revenue | $139,927 | $89,077 | $49,005 | $22,593 |
| % Growth | 57.1% | 81.8% | 116.9% | – |
| Gross Profit | $98,943 | $53,765 | $21,328 | $4,517 |
| % Margin | 70.7% | 60.4% | 43.5% | 20% |
| EBITDA | -$23,760 | -$41,037 | -$57,779 | -$41,010 |
| % Margin | -17% | -46.1% | -117.9% | -181.5% |
| Net Income | -$27,455 | -$48,608 | -$66,756 | -$48,688 |
| % Margin | -19.6% | -54.6% | -136.2% | -215.5% |
| EPS Diluted | -0.71 | -1.41 | -2.41 | -1.78 |
| % Growth | 49.6% | 41.5% | -35.4% | – |
| Operating Cash Flow | -$16,946 | -$41,593 | -$58,850 | -$44,708 |
| Capital Expenditures | -$5,440 | -$4,814 | -$2,393 | -$1,940 |
| Free Cash Flow | -$22,386 | -$46,407 | -$61,243 | -$46,648 |